Lack of associations of chemotactic cytokines with viral burden, disease progression, or lymphocyte subsets in HIV-infected individuals

Clinical Immunology and Immunopathology

Volumn 85, Issue 1, 1997, Pages 21-27

  Krowka, John F ^a   Gesner, Marianne L ^a   Ascher, Michael S ^a   Sheppard, Haynes W ^a  

^a VIRAL AND RICKETTSIAL DISEASE LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD8 ANTIGEN; CHEMOTACTIC FACTOR; CYTOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NEOPTERIN; RANTES;

ARTICLE; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIREMIA;

EID: 0031259932     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4411     Document Type: Article

References (39)

1. Ho D. D. HIV-1 vireaemia and influenza. Lancet. 339:1992;1549.
2. Mulder J., McKinney N., Christopherson C., Sninsky J., Greenfield J., Kwok S. A rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 32:1994;292-300.
3. Lee T. H., Sheppard H. W., Reis M., Dondero D., Osmond D., Busch M. P. Circulating HIV 1-infected cell burden from seroconversion to AIDS: Importance of postseroconversion viral load on disease course. J. AIDS. 7:1994;381-389.
4. Bremermann H. J. Mechanisms of HIV persistence: Implications for vaccines and therapy. J. AIDS. 9:1995;459-483.
5. Sheppard H. W., Lang W., Ascher M. S., Vittinghoff E., Winkelstein W. The characterization of non-progressors: Long-term HIV-1 infection with stable CD4+ T-cell levels. AIDS. 7:1993;1159-1166.
6. Henrard D. R., Phillips J. F., Muenz L. R., Blattner W. A., Wiesner D., Eyster M. E., Goedert J. J. Natural history of HIV-1 cell-freeviremia. J. Am. Med. Assoc. 274:1995;554-558.
7. Mellors J. W., Rinaldo C. R., Gupta P., White R. M., Todd J. A., Kingsley L. A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 272:1996;1167-1170.
8. +. Science. 234:1986;1563-1566.
9. +. Science. 270:1995;1811-1815.
10. Paxton W. A., Martin S. R., Tse D., O'Brien T. R., Skurnick J., VanDevanter N. L., Padian N., Braun J. F., Kotler D. P., Wolinsky S. M., Koup R. A. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nature Med. 2:1996;412-417.
11. Taub D. D., Lloyd A. R., Wang J. M., Oppenheim J. J., Kelvin D. J. The effects of human recombinant MIP-1α, MIP-1β, and RANTES on the chemotaxis and adhesion of T cell subsets. The Chemokines. 1993;Plenum Press, New York. p. 139-146.
12. ++. Eur. J. Immunol. 25:1995;751-756.
13. ++. FASEB J. 8:1994;1055-1060.
14. +. J. Immunol. 156:1996;4476-4483.
15. Mackewicz C. E., Barker E., Levy J. A. Role of β-chemokines in suppressing HIV replication. Science. 274:1996;1393-1394.
16. Feng Y., Broder C. C., Kennedy P. E., Berger E. A. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 272:1996;872-877.
17. Deng H., Liu R., Ellmeir W., Choe S., Unutmaz D., Burkhart M., DiMarzo P., Marmon S. M., Sutton R. E., Hill C. M., Davis C. B., Peiper S. C., Schall T. J., Littman D. R., Landau N. R. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
18. +. Nature. 381:1996;667-673.
19. Doranz B. J., Rucker J., Yi Y., Smyth R. J., Samson M., Peiper S. C., Parmentier, Collman R. G., Doms R. W. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 85:1996;1149-1158.
20. Liu R., Paxton W. A., Choe S., Ceradini D., Martin S. R., Horuk R., MacDonald M. E., Stuhlmann H., Koup R., Landau N. R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 86:1996;367-377.
21. Samson M., Libert F., Doranz B. J., Rucker J., Liesnard C., Farber C-M., Saragosti S., Lapoumeroulie C., Cagnaux J., Forceille C., Muyldermanns G., Verhofsteded C., Burtonboy G., Georges M., Imai T., Rana S., Yanji Y., Smyth R. J., Dollmann R. G., Doms R. W., Vassart, Parmentier M. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 382:1996;722-725.
22. Lang W., Anderson R. E., Perkins H., Grant R. M., Lyman D., Winkelstein W., Royce R., Levy J. A. Clinical, immunologic, and serologic findings in men at risk for acquired immunodeficiency syndrome. J. Am. Med. Assoc. 257:1987;326-330.
23. Sheppard H. W., Ascher M. S., McRae B., Anderson R. E., Lang W., Allain J. P. The initial immune response to HIV and immune system activation determine the outcome of HIV disease. J. AIDS. 4:1991;704-712.
24. Levy J. A., Hoffman A. D., Kramer S. M., Landis J. A., Shimabukuro J. M., Oshiro L. S. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science. 225:1984;840-842.
25. Castro K. G., Ward J. W., Slutskey L., Buehler J. W., Jaffe H. W., Berkelman R. L., Curran J. W. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Clin. Infect. Dis. 17:1993;802-810.
26. Bubel S., Wilhelm D., Entelmann M., Kirchner H., Kluter H. Chemokines in stored platelet concentrates. Transfusion. 36:1996;445-449.
27. ++-++. J. Infect. Dis. 170:1994;775-781.
28. McKenzie S. W., Dallalio G., North M., Frame P., Means R. T. Serum chemokine levels in patients with non-progressing HIV infection. AIDS. 10:1996;F29-F33.
29. Zanussi S., D'Andrea M., Simonelli C., Tirelli U., DePaoli P. Serum levels of RANTES and MIP-1α in HIV-positive long-term survivors and progressor patients. AIDS. 10:1996;1431-1432.
30. +. Immunol. Lett. 53:1996;105-108.
31. Tedla N., Palladinetti P., Kelly M., Kumar R. K., DiGirolamo N., Chattophadhay U., Cooke B., Truskett P., Dwyer J., Wakefield D., Lloyd A. Chemokines and T lymphocyte recruitment to lymph nodes in HIV infection. Am. J. Pathol. 148:1996;1367-1373.
32. Sasseville V. G., Smith M. M., Mackay C. R., Pauley D. R., Mansfield K. G., Ringler D. J., Lackner A. A. Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. Am. J. Pathol. 149:1996;1459-1467.
33. Cook D. N., Beck M. A., Coffman T. M., Kirby S. L., Sheridan J. F., Pragnell I. B., Smithies O. Requirement of MIP-1α for an inflammatory response to viral infection. Science. 269:1995;1583-1585.
34. Lehner T., Wang Y., Cranage M., Bergmeier L. A., Mitchell E., Tao L., Hall G., Dennis M., Cook N., Brookes R., Klavinskis L., Jones I., Doyle C., Ward R. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nature Med. 2:1996;767-775.
35. Weiss R. A., Clapham P. R. Hot fusion of HIV. Nature. 381:1996;647-648.
36. Sharma V., Xu M., Ritter L. M., Wilkie N. M. HIV-1tat. Biochem. Biophys. Res. Commun. 223:1996;526-533.
37. Dean M., Carrington M., Winkler C., Huttley G. A., Smith M. W., Allikmets R., Goedert J. J., Buchbinder S. P., Vittinghoff E., Gomperts E., Donfield S., Vlahov D., Kaslow R., Saah A., Rinaldo C., Detels R. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study, and O'Brien, S. J., Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science. 273:1996;1856-1862.
38. Huang Y., Paxton W. A., Wolinsky S. A., Neumann A. U., Zhang L., He T., Kang S., Ceradini D., Jin Z., Yazdanbakhsh, Kunstman K., Erickson D., Dragon E., Landau N. R., Phair J., Ho D. D., Koup R. A. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med. 2:1996;1240-1243.
39. Michael N. L., Chang G., Louie L. G., Mascola J. R., Dondero D., Birx D. L., Sheppard H. W. CCR-5 gene defects and viral phenotype are associated with nonprogressive HIV-1 disease. Nature Med. 3:1997;338-340.